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Summary The effect of hypobaric hypoxia on the in vivo binding of misonidazole was investigated in normal
mice and mice bearing T50/80 or CA NT mammary carcinomas. After the intraperitoneal injection of
radiolabelled misonidazole, mice were randomised to breathe either room air or air at 0.5 atmospheres. The
distribution of misonidazole in liver, kidney, heart, spleen and tumour tissue, 24h later, was studied by
scintillation counting and by autoradiography. Significantly higher misonidazole binding occurred in the
livers ( x 2.5), kidneys ( x 2.4), spleens ( x 2.9) and hearts ( x 1.8) of hypoxic mice compared to controls.
Hypobaric hypoxia was associated with a greater than four-fold increase in misonidazole binding within T50/
80 tumours. However, significantly higher binding was not demonstrated within CA NT tumours after
exposure of tumour-bearing animals to hypoxic conditions. In autoradiographs of hypoxic liver, labelling was
intense in regions near to hepatic veins but sparse in areas surrounding portal tracts. This pattern was striking
and consistent. In hypoxic kidney, labelling was most intense over tubular cells, less intense over glomeruli
and sparse in the renal medulla. It is likely that the hepatic and renal cortical distributions of misonidazole
binding reflect local oxygen gradients.
Hypoxic cells are relatively resistant to the effects of ionising
radiation and hypoxic tumour cells are probably responsible
for local treatment failure in a proportion of cancer patients
treated by radiotherapy (Gray et al., 1953). Cellular hypoxia
within tumours has been measured directly using oxygen
electrodes (Cater & Silver, 1960) and indirectly by studying
the effects of irradiation. Neither of these methods can
accurately localise hypoxic cells or show their histological
distribution. Oxygen electrodes can only measure the average
oxygen tension in a poorly defined area of tissue containing
many cells. Radiation experiments provide only approximate
estimates of hypoxic fraction.
A method for labelling hypoxic cells within tumours was
described by Chapman et al. (1981) which used the radio-
sensitizing drug misonidazole (MISO). It has been shown
that reductive metabolism of MISO is enhanced under
hypoxic conditions (Smith & Born, 1984) and that reduced
metabolites covalently bind to hypoxic cells in vitro
(Varghese et al., 1976). Using autoradiography, Chapman
showed that radiolabelled MISO binds preferentially in vivo
to cells within murine tumours which are likely to be
hypoxic, i.e. cells near to areas of necrosis and far from
capillaries. Using liquid scintillation counting, he
demonstrated that relatively large amounts of MISO become
bound within the tumours and livers of tumour-bearing
mice. (The liver is the major site of MISO metabolism.) Hirst
et al. (1985) demonstrated that MISO binding within RIF-I
and EMT-6 tumours increased with acute anaemia and
reflected changes in the hypoxic fraction as estimated by
radiation experiments.
The effect of local oxygen tension on in vivo MISO
binding in normal tissue has not previously been investigated
in any detail. If MISO binding is truly determined by the
cellular pO2, then both normal and neoplastic tissues should
bind an increased amount of MISO under hypoxic
conditions. If an oxygen tension gradient normally exists in
an organ then MISO binding should also exhibit a gradient.
Such a gradient is thought to exist in the liver between the
portal tracts and the hepatic veins but direct measurements
cannot be made in vivo without disturbing the hepatic
architecture.
The use of a hypobaric chamber to reduce the pO2 of
inspired air markedly is a relatively simple and reproducible
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way to induce hypoxia in laboratory animals, In this study
we investigated the effect of hypobaric hypoxia on the
distribution of radiolabelled MISO in normal and tumour-
bearing mice. We used liquid scintillation counting to give a
quantitative measure of MISO binding within organs and
autoradiography to show the histological distribution of the
compound.
Materials and methods
MISO distribution was investigated in normal adult male
mice of three different strains: C57BL6, CBA and B6D2F.
During each experiment mice had free access to food and
tap water. Experiments were conducted in accordance with
the guidelines of the Animals (Scientific Procedures) Act,
1986.
Tumour systems
Two transplantable murine mammary carcinomas were
studied. Both tumours arose spontaneously and have been
passaged in the strain of origin by subcutaneous
implantation of either tumour fragments or a thick cell
suspension. The T50/80 carcinoma and inbred male B6D2 1
mice were kindly supplied by Dr James V. Moore of the
Paterson Laboratories, Christie Hospital, Manchester. Dr
Anamaria Rojas of the Gray Laboratory, Mount Vernon
Hospital, Northwood, kindly supplied us with the CA NT
tumour and inbred male CBA mice. Tumours were grown in
the rear dorsum. The CA NT tumour grows rapidly (volume
doubling time 2.5 days), is poorly differentiated and
contained extensive areas of necrosis, whereas the T50/80
tumour grows more slowly (volume doubling time 4.5 days)
and has a well marked 'corded' structure. T50/80 tumours
with mean diameters 6-12mm and CA NT tumours of mean
diameter 10-12mm were used in this study.
Hypoxic chamber
The hypoxic chamber is a sturdy steel cylinder, sealed at one
end and with an airtight door at the other. Air is extracted
from the chamber by a vacuum pump and an inlet valve
allows a variable flow of air to enter from the outside. By
varying the flow through the inlet valve the desired
barometric pressure, as measured by an aneroid barometer,
can be maintained within the chamber. In experiments
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involving hypobaric hypoxia, a pressure of 0.5 atmospheres
was maintained within the chamber for 24h. All mice
survived these conditions without apparent ill-effect.
Radio/labelled MISO
Unlabelled MISO and a limited supply of 14C-labelled
MISO (specific activity 1.96MBqmg-1 were kindly supplied
by Hoffman LaRoche Limited (Welwyn Garden City,
Herts.). We used the method of Born & Smith (1983) to
label MISO with tritium to a specific activity of
5.99 MBq mg- I
MISO was administered intraperitoneally, dissolved in
0.2ml of sterile normal saline. Mice were randomly allocated
to either a control group, which breathed room air, or a
'hypoxic' group, which was placed in the hypoxic chambet
immediately after MISO administration. All mice were killed
by cervical dislocation 24h after injection with the drug.
Although the apparent half-life of MISO in mice is relatively
short at 1.5-3.0h, (Chin & Rauth, 1981; Pederson et al.,
1979),' this 24-h period was necessary to allow the excretion
of unbound drug.
0.
m 0
0.
Heart Liver Spleen Kidney
Figure 1 Mean percentage of administered MISO dose bound
per gram of tissue under hypoxic (n = 15) and normal (n = 14)
conditions.
Liquid scintillation counting
The livers, spleens, hearts, kidneys and, where appropriate,
tumours of MISO-treated mice were removed immediately
after death. When a tumour contained a necrotic core, tissue
frolll the tumour edge was used for scintillation counting.
Portions of each organ, weighing 60-200mg, were minced
with scissors and each added, together with 1 ml of distilled
water and 4 drops of 6% hydrogen peroxide, to vials
containing 10ml of Protosol tissue solubiliser (New England
Nuclear, Boston, MA). Tissues were then left overnight in an
ultrasonic water bath to dissolve. Biofluor liquid scintillation
cocktail (New England Nuclear) was added, 10ml of each
sample, and the vials were left for 5 days to allow chem-
iluminescence to subside. The vials were then counted in a
Packard 2000 CA liquid scintillation analyser (Packard
Instrument Company, Downers Grove, IL) and the number
of disintegrations per gram of tissue calculated.
Autoradiogrcaphy
A portion of each organ was fixed in 10% buffered formalin
and embedded in paraffin. Sections of 5jim thickness were
mounted on chromic acid-washed microscope slides which
had been 'subbed' with gelatin. Slides were then de-waxed
and placed in distilled water. In a dark-room the slides were
dipped in liquid nuclear emulsion, either Ilford K5 or G5
(Ilford Limited, London). After 6 weeks the autoradiographs
were developed in Polycon (May & Baker, Dagenham,
Essex) diluted 1 in 4 with distilled water and then fixed in
30% sodium thiosulphate. The sections were finally stained
with Haematoxylin and Eosin.
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Figure 2 Mean percentage of administered MISO dose bound
per gram of tissue in mice bearing T50/80 tumours under
hypoxic (n=9) and normal (n=8) conditions.
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Results
Scintillation counting
Hypobaric hypoxia caused an increase in the binding of
labelled MISO to all of the non-neoplastic tissues studied, in
both normal and tumour-bearing mice. The effect was seen
in all three strains of mice and it occurred' with both 14C-
and 3H-labelled MISO. Pooled data from a number of
experiments, in which mice received between 0.37 and
3.7MBq of labelled MISO, are shown in Figure 1. In our
initial studies, small amounts of labelled drug were used
because supplies were limited but in later experiments larger
quanities could be employed. Because of the range of doses
used, results are expressed as a percentage of administered
dose bound per gram of tissue. A similar pattern of MISO
distribution occurred at all doses.
The livers of hypoxic mice bound of average 2.5 times as
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Figure 3 Mean percentage of administered MISO dose bound
per gram of tissue in mice bearing CA NT tumours under
hypoxic (n =5) and normal (n=5) conditions.
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much MISO as did controls. MISO binding in hypoxic
kidney was increased by a factor of 2.4, binding in hypoxic
heart by 1.8 and binding in hypoxic spleen by 2.9.
Significantly more labelled MISO was found per gram of
heart (P<0.0006), liver (P<0.0007), spleen (P<0.0007) and
kidney (P<0.0001) in hypoxic mice compared to controls
(unpaired t test).
The distribution of MISO in tumour-bearing mice is
shown in Figures 2 and 3. Under normal conditions, MISO
binding within the T50/80 tumour was only moderately high.
However, under hypoxic conditions a greater than four-fold
increase in MISO binding was observed (Figure 2). This
increase was statistically significant (P=0.03, unpaired t
test).
A very different pattern was seen in the case of the
CA NT tumour (Figure 3). Under normal conditions, the
mean percentage of MISO binding within this tumour
exceeded that in the T50/80 tumour by a factor of more than
2.5. Nevertheless, the level of MISO binding found within
the tumours of CA NT-bearing mice exposed to hypoxia was
not significantly higher than that observed in control
tumours, although a trend towards higher binding was noted
in hypoxic mice. Under hypoxic conditions MISO binding in
the T50/80 tumour exceeded that found in the CA NT
tumour. Non-neoplastic tissue of tumour-bearing mice
showed a similar pattern of MISO binding to that of normal
mice.
Autoradiography
A characteristic histological distribution of MISO was
observed within the livers of both normal and hypoxia-
exposed mice. In autoradiographs of hypoxic liver tissue,
high concentrations of silver grains were observed around
w*w -w '.w _
Figure 4 Autoradiographs of a portal tract and an adjacent
hepatic vein from the liver of an hypoxic mouse given 10jiCi of
14C-labelled MISO.
Figure 5 (a) Autoradiograph of renal cortex, showing two
glomeruli, from an hypoxic mouse given 50pCi of 14C-labelled
MISO. (b) Autoradiograph of renal medulla from the same
mouse.
hepatic veins (zone III of hepatic lobule) and low grain
concentrations were seen near to portal tracts (zone I of the
hepatic lobule). Regions of liver parenchema betwen zones I
and III (zone II) had intermediate grain concentrations.
Examples of these findings are shown in Figure 4. The
spatial distribution of grains was similar in non-hypoxic liver
but the pattern was less well marked. This pattern was
observed in all autoradiographs with sufficient grains for
evaluation.
In hypoxic kidney, very few grains were observed in the
medulla whereas high concentrations of grains were observed
over renal tubular cells. Relatively few grains were seen over
glomeruli (Figure 5). Satisfactory autoradiographs of non-
hypoxic kidney, spleen or heart have not yet been made
because these tissues have bound relatively small amounts of
labelled MISO. Autoradiographs of hypoxic heart and spleen
showed a rather homogeneous distribution of grains.
In autoradiographs of T50/80 tumours, high grain
concentrations were seen adjacent to areas of necrosis. A
detailed investigation of the distribution of MISO in auto-
radiographs of tumours from the normal and hypoxic mice
has not yet been made.
Discussion
This study confirms the value of MISO binding as a marker
for cellular hypoxia in both neoplastic and normal tissues.
Previous investigations have concentrated almost entirely on
the usefulness of MISO in tumour systems, although Smith
(1983) showed that isolated perfused rat livers bound more
MISO under hypoxic conditions and Garrecht & Chapman
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(1983) have shown that the ischaemic myocardium of
isoprenaline-treated mice bound twice as much as the
myocardium of normal mice. The fact that hypoxic
conditions cause increased MISO binding to normal cells
suggests that MISO binding may be useful in the study of
conditions causing hypoxia in otherwise normal tissues. Our
results also give support to Chapman's contention that
variations in MISO binding within tumours are principally
due to cellular hypoxia rather than to other metabolic or
genetic abnormalities affecting neoplastic cells.
The profound increase in MISO binding that was observed
within the T50/80 tumour under hypoxic conditions, far
exceeding that seen in other tissues studied, may occur
because many cells within these tumours are normally on the
verge of hypoxia. A relatively small reduction in the oxygen
supply to the tumour could therefore cause a dis-
proportionately large increase in MISO binding. The hypoxic
fraction of this tumour has been estimated at 61% in
experiments involving irradiation of tumours either lying
freely in the beam path or with their blood supply occluded
by a clamp, using a growth delay assay to assess tumour
response (Moore, 1988). The true hypoxic fraction may be
lower than this because the mice used in this study were
anaesthetised with enflurane to facilitate their restraint in jigs
before irradiation. Recent evidence suggests that the mice
may not have recovered fully from the anaesthetic when
irradiated (J.V. Moore, personal communication).
Our results support the contention by Hirst et al. (1985)
that the increase in MISO binding observed in the tumours
of mice which are rendered acutely anaemic is due to
hypoxia rather than to haemodynamic changes induced by
venesection and infusion of plasma. MISO binding may
prove to be a useful way of assessing the effect in vivo of
drugs that may kill cells within solid tumours by inducing
hypoxia.
It is more difficult to explain why a large increase in
MISO binding did not occur in the CA NT tumour under
hypoxic conditions. The radiobiological hypoxic fraction of
this tumour is reported to be 7-18% under normal
conditions (Denekamp, 1984). Since our method for inducing
hypoxia does not cause vascular occlusion within the
tumours, it is likely that the availability of MISO for binding
to hypoxic cells was not altered. Hirst et al. (1985) have
suggested that, in some tumours, MISO binding may not
correlate well with the radiobiological hypoxic fraction. One
possible explanation for our results is that the CA NT
tumour contains a very high proportion of hypoxic cells
under normal conditions and that the reported radio-
biological hypoxic fraction, which reflects clonogenic cells, is
an underestimate of the total number of cells which are truly
hypoxic. If this is the case then a large increase in MISO
binding would be unlikely to occur under hypoxic conditions
because most cells would already bind MISO.
The histological distribution of MISO binding within the
livers of both normal and hypoxia-exposed mice provides
compelling evidence in support of the contention that MISO
binding within tissues is closely related to the cellular pO2.
The distribution of MISO in hypoxic kidney, however, is
difficult to explain solely on the basis of oxygen tension
gradients. The cortical distribution, with relatively low
concentrations of grains over the glomeruli and high
concentrations over the tubules, is not surprising because
glomeruli are relatively well perfused and therefore MISO
binding in the cortex may be governed mainly by cellular
pG2. However, the renal medulla is known to have a lower
PO2 than the cortex and yet the binding of MISO in this
region was extremely low. One possible explanation for this
is the shutdown in blood flow to the renal medulla that
normally occurs under hypoxic conditions (Frohnert, 1978).
This would greatly reduce the amount of circulating MISO
entering the region and hence reduce the opportunities for
binding. Another possibility is that cells in the renal medulla
might contain relatively small amounts of the reductase
enzymes which produce the reactive reduced metabolites.
The results of this study show that MISO binding to
tissues in vivo is markedly affected by hypoxia. The
histological distribution of the compound in hypoxic liver,
reflecting the oxygen tension gradient between portal tract
and hepatic veins, strongly supports the contention that the
distribution of MISO binding within tumours is governed by
local variations in oxygenation. MISO binding should prove
to be a useful tool for investigation cellular hypoxia within
neoplasms. The potential of this compound as a marker for
tissue hypoxia in non-neoplastic tissues has yet to be
realised.
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